FA
KRON

Forefront Analytics’s Kronos Bio KRON Stock Holding History

Forefront Analytics’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-93,190
Closed -$88.5K – 56
2024
Q4 		$88.5K Buy
93,190
+2,192
+2% +$2.07K 0.04% 59
2024
Q3 		$91K Sell
90,998
-44,000
-33% -$48.7K 0.04% 62
2024
Q2 		$167K Buy
134,998
+57,867
+75% +$58.9K 0.08% 57
2024
Q1 		$100K Buy
77,131
+27,963
+57% +$31.9K 0.05% 61
2023
Q4 		$61.5K Buy
49,168
+9,200
+23% +$10.2K 0.03% 65
2023
Q3 		$52K Buy
39,968
+900
+2% +$1.45K 0.03% 65
2023
Q2 		$67.2K Sell
39,068
-227
-0.6% -$360 0.04% 61
2023
Q1 		$57.4K Buy
+39,295
New +$75.3K 0.03% 70

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Forefront Analytics's KRON Position: Q1 2025 in Review

Forefront Analytics sold out of Kronos Bio (KRON) in Q1 2025, closing a stake of 93,190 shares — an estimated $88.5K sold.

Forefront Analytics first reported a position in KRON in Q1 2023 and held it in 8 quarters. The position peaked at $167K in Q2 2024. 47 funds tracked by Wall St. Rank hold KRON as of Q1 2025.

  • Forefront Analytics reported no remaining Kronos Bio position as of Q1 2025 after selling out during the quarter.
  • Forefront Analytics sold 93,190 Kronos Bio shares in Q1 2025, an estimated $88.5K.
  • Forefront Analytics first reported a position in Kronos Bio in Q1 2023 and held it in 8 quarters.
  • Forefront Analytics's Kronos Bio position peaked at $167K in Q2 2024.
  • 47 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2025.

Based on Forefront Analytics's 13F filing for Q1 2025, filed 13 May 2025.